Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma

Abstract Patients with relapsed/refractory early T-cell precursor lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) respond poorly to traditional therapy and have dismal prognosis. CD7 is a promising therapeutic targets for chimeric antigen receptor modified T cell therapy (CART) due to its widely expre...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Hai-ping Dai, Wei Cui, Qing-ya Cui, Wen-juan Zhu, Hui-min Meng, Min-qing Zhu, Xia-ming Zhu, Lin Yang, De-pei Wu, Xiao-wen Tang
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2022-02-01
Sarja:	Biomarker Research
Aiheet:	Chimeric antigen receptor T-cells CD7 Early T-cell precursor lymphoblastic leukemia/lymphoma Relapsed / refractory
Linkit:	https://doi.org/10.1186/s40364-022-00352-w
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!